Media Release


Delisting of IGEA Pharma N.V., Hoofddorp NL – Formal delisting

By decision of 31 October 2023, the Appeals Board of SIX Group AG dismissed the appeal of IGEA Pharma N.V. against the decision of the Regulatory Board of SIX Group AG to delist all registered shares of IGEA Pharma N.V. (Swiss Security Number 41’217’478 / ISIN NL0012768675) with a nominal value of EUR 0.01 each listed on SIX Swiss Exchange AG pursuant to Art. 58 para. 1 ciph. 2 Listing Rules (LR) due to the issuer’s solvency being in serious doubt.

The delisting is therefore legally binding. The formal delisting of IGEA Pharma N.V. will take place on 20 December 2023.

The decision regarding the delisting of IGEA Pharma N.V. is available on the Website of SER.

The applicable directive is available at the following link.